Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
CAPR logo

CAPR

NSC
Capricor Therapeutics Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Sunday 13th July 2025
7.64
-3.76 (-32.98%)
Prev Close:11.4
Open:7.0
Bid:7.57
Ask:7.67
52 Week Range
3.52
23.40
Volume:2,834,788
Mkt Cap:465 M
Price Target
$8.79
+15.1%
Financials

Financial Statements

CAPR - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Depreciation And Amortization1 M1 M533131.0243532.0139560.0-128680.0-114376.0-94968.0-85888.0
Gain On Sale Of PPE-112805.0-6041.0-34266.0-7905.0-2720.0
General And Administrative Expense15 M13 M10 M8 M6 M4 M5 M5 M5 M4 M
Gross Profit Margin (profit Margin After CGS)22 M25 M3 M244898.0310250.03 M4 M6 M
Interest Expense Non Operating398807.0344665.0248626.0
Misc Other Special Charges2 M2 M712117.0923827.032943.01 M2 M3 M14407.03113.0
Net Income (loss)-40 M-22 M-29 M-20 M-14 M-8 M-15 M2 M-19 M-13 M
Net Income Common Stockholders-40 M-22 M-29 M-20 M-14 M-8 M-15 M2 M-19 M-13 M
Net Income Continuous Operations-40 M-22 M-29 M-20 M-14 M-8 M-15 M2 M-19 M-13 M
Net Non Operating Interest Income Expense15 M-344665.0-248626.0
Normalized Income-40 M-16 M
Operating Income-43 M-24 M-30 M-21 M-14 M-9 M-17 M-16 M-17 M-13 M
Operating Income Before Depreciation (EBITDA)-39 M-21 M-29 M-21 M-14 M-7 M-15 M3 M-18 M-12 M
Operating Expense65 M49 M32 M21 M14 M9 M-17 M-16 M-21 M-18 M
Other Gand A15 M13 M10 M8 M6 M4 M5 M5 M5 M4 M
Other Impairment Of Capital Assets2 M
Other Operating Expenses841429.0792842.0129726.0
Rent And Landing Fees-16229.05 M5 M5 M4 M
Research Expense50 M36 M22 M14 M9 M5 M12 M11 M16 M14 M
Salaries And Wages10 M7 M-700984.0-2 M-2 M-2 M
Total Income Available For Interest Expense (EBIT)-40 M-22 M-30 M-21 M-14 M-8 M-15 M3 M-18 M-13 M
Total Revenues22 M25 M3 M244898.0310250.02 M3 M4 M6 M
Total Expenses65 M49 M32 M21 M14 M9 M-17 M-16 M-21 M-18 M
Total Revenue22 M25 M3 M244898.0310250.02 M3 M4 M6 M
Amord2165.04330.0-43276.0-43276.0-49206.0-48749.0
Avgshs35 M27 M25 M23 M16 M4 M3 M2 M2 M2 M
Avgshsdt35 M27 M25 M23 M16 M4 M3 M3 M2 M2 M
Basiceps-1.15-0.83-1.18-0.87-0.881.0
Basicepscont-1.15-0.83-1.18-0.87-0.88
Depamor1 M1 M533131.0243532.0139560.0-128680.0-114376.0-94968.0-85888.0
Dileps-1.15-0.83-1.18-0.87-0.88-2.06-10.40.9-10.1-8.1
Dilepscont-1.15-0.83-1.18-0.87-2.06
Intinc16 M
Netincdisc-40 M-22 M-29 M-20 M-14 M-8 M-15 M2 M-19 M-13 M
Othincexp-2 M-2 M677851.0-915922.0-32943.0-1 M-2 M-3 M1 M-3113.0
Pretaxinc-40 M-22 M-29 M-20 M-14 M-8 M-15 M2 M-19 M-13 M
Resdev50 M36 M22 M14 M9 M5 M12 M11 M16 M14 M
Sga15 M13 M10 M8 M6 M4 M5 M5 M5 M4 M
Shsout46 M31 M25 M24 M23 M9 M3 M3 M2 M2 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader